title: [Pollinosis].
abstract: Pollinosis is an extremely common disorder affecting between 10 to 30% of the population. There are regional and seasonal variations with allergies occurring between february (in south of France) and autumn. Pollen calenders allow one to identify the pollens specific to each region. Treatment is based on the utilisation of antihistaminic and local antiinflammatory agents. Specific desensitization is efficacious when quality extracts are used, but should be reversed for particular cases as the therapeutic risk should in no case exceed that of the illness.
authors: Clinique des maladies respiratoires, Hôpital Amaud de Villeneuve, Montpellier.
authors: H
authors: H
authors: Dhivert-Donnadieu
authors: J
authors: J
authors: Bousquet
mesh_terms: D000287:Administration, Topical; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D004205:Cromolyn Sodium / Q000627:therapeutic use; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D011058:Pollen / Q000145:classification; D006255:Rhinitis, Allergic, Seasonal / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy
chemical_list: D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D004205:Cromolyn Sodium
vernacular_title: Pollinose.